Analysis of traditional and nontraditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan

Diabetes Research and Clinical Practice

Volumn 81, Issue 3, 2008, Pages 331-337

  Chou, Chen Kai ^a   Weng, Shao Wen ^a   Chang, Hsueh Wen ^b   Chen, Chih Yin ^a   Su, Sheng Chi ^a   Liu, Rue Tsuan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Ankle brachial index; Chronic kidney disease; Peripheral arterial disease

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; AGED; ALBUMINURIA; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; TAIWAN;

AGED; ARTERIAL OCCLUSIVE DISEASES; BLOOD PRESSURE; BRACHIAL ARTERY; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RISK FACTORS; TAIWAN;

EID: 48949091650     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.04.027     Document Type: Article

References (38)

1. American Diabetes Association, Peripheral arterial disease in people with diabetes, Diabetes Care 26 (2003) 3333-3341.
2. Newman A.B., Shemanski L., Manolio T.A., Cushman M., Mittelmark M., Polak J.F., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler. Thromb. Vasc.Biol. 19 (1999) 538-545
3. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), CAPRIE Steering Committee, Lancet 348 (1996) 1329-1339.
4. Resnick H.E., Carter E.A., Sosenko J.M., Henly S.J., Fabsitz R.R., Ness F.K., et al. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care 27 (2004) 1885-1891
5. Fonseca V., Desouza C., Asnani S., and Jialal I. Nontraditional risk factors for cardiovascular disease in diabetes. Endocr. Rev. 25 (2004) 153-175
6. Wattanakit K., Folsom A.R., Selvin E., Weatherley B.D., Pankow J.S., Brancati F.L., et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 180 (2005) 389-397
7. Adler A.I., Stevens R.J., Neil A., Stratton I.M., Boulton A.J., and Holman R.R. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25 (2002) 894-899
8. Tseng C.H., Tai T.Y., Chen C.J., and Lin B.J. Ten-year clinical analysis of diabetic leg amputees. J. Formos Med. Assoc. 93 (1994) 388-392
9. Tseng C.H. Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Angiology 54 (2003) 331-338
10. Tseng C.H. Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with type 2 diabetes. Diabet. Med. 21 (2004) 724-729
11. Tseng C.H. Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan. Diabetes Care 27 (2004) 517-521
12. Hozawa A., Ohmori K., Kuriyama S., Shimazu T., Niu K., Watando A., et al. C-reactive protein and peripheral artery disease among Japanese elderly: the Tsurugaya Project. Hypertens. Res. Clin. Exp. 27 (2004) 955-961
13. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med. 15 (1998) 539-553
14. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens. Res. Clin. Exp. 25 (2002) 359-364
15. Milazzo D., Biasucci L.M., Luciani N., Martinelli L., Canosa C., Schiavello R., et al. Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events. Am. J. Cardiol. 84 (1999) 459-461
16. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Centers for disease control and P, American heart A: markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107 (2003) 499-511
17. Tapp R.J., Shaw J.E., de Courten M.P., Dunstan D.W., Welborn T.A., and Zimmet P.Z. AusDiab Study G: Foot complications in Type 2 diabetes: an Australian population-based study. Diabet. Med. 20 (2003) 105-113
18. Fowkes F.G., Housley E., Riemersma R.A., Macintyre C.C., Cawood E.H., Prescott R.J., et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am. J. Epidemiol. 135 (1992) 331-340
19. Meijer W.T., Grobbee D.E., Hunink M.G., Hofman A., and Hoes A.W. Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch. Intern. Med. 160 (2000) 2934-2938
20. Stout R.W. Insulin and atheroma. 20-yr perspective. Diabetes Care 13 (1990) 631-654
21. de Zeeuw D., Remuzzi G., Parving H.H., Keane W.F., Zhang Z., Shahinfar S., et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110 (2004) 921-927
22. de Zeeuw D., Remuzzi G., Parving H.H., Keane W.F., Zhang Z., Shahinfar S., et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int. 65 (2004) 2309-2320
23. Bo S., Ciccone G., Rosato R., Gancia R., Grassi G., Merletti F., et al. Renal damage in patients with Type 2 diabetes: a strong predictor of mortality. Diabet. Med. 22 (2005) 258-265
24. Kallio M.F.C., Groop P.H., Groop L., and Lepantalo M. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care 26 (2003) 1241-1245
25. Tseng C.H., Tseng C.P., Tai T.Y., and Chong C.K. Effect of angiotensin blockade on the association between albuminuria and peripheral arterial disease in elderly Taiwanese patients with type 2 diabetes mellitus. Circ. J. 69 (2005) 965-970
26. So W.Y., Kong A.P., Ma R.C., Ozaki R., Szeto C.C., Chan N.N., et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 29 (2006) 2046-2052
27. Muntner P., He J., Hamm L., Loria C., and Whelton P.K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J. Am. Soc. Nephrol. 13 (2002) 745-753
28. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
29. Fang J., and Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283 (2000) 2404-2410
30. Culleton B.F., Larson M.G., Kannel W.B., and Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann. Intern. Med. 131 (1999) 7-13
31. Chien K.L., Hsu H.C., Sung F.C., Su T.C., Chen M.F., and Lee Y.T. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 183 (2005) 147-155
32. Wheeler J.G., Juzwishin K.D., Eiriksdottir G., Gudnason V., and Danesh J. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med./Public Library Sci. 2 (2005) e76
33. Zebrack J.S., Muhlestein J.B., Horne B.D., and Anderson J.L. Intermountain Heart Collaboration Study G: C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J. Am. Coll. Cardiol. 39 (2002) 632-637
34. Di Napoli M., Papa F., and Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32 (2001) 917-924
35. Rossi E., Biasucci L.M., Citterio F., Pelliccioni S., Monaco C., Ginnetti F., et al. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 105 (2002) 800-803
36. Tseng C.H., Chong C.K., Lin B.J., Chen C.J., and Tai T.Y. Atherosclerotic risk factors for peripheral vascular disease in non-insulin-dependent diabetic patients. J. Formos. Med. Assoc. 93 (1994) 663-667
37. Lien W.P., Lai L.P., Shyu K.G., Hwang J.J., Chen J.J., Lei M.H., et al. Low-serum, high-density lipoprotein cholesterol concentration is an important coronary risk factor in Chinese patients with low serum levels of total cholesterol and triglyceride. Am. J. Cardiol. 77 (1996) 1112-1115
38. Tall A.R. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J. Clin. Invest. 86 (1990) 379-384